CervoMed Inc — Dividend History & Yield (NASDAQ:CRVO) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Nachrichten

CervoMed: Wirkstoffkandidat Neflamapimod für britische ALS-Studienplattform ausgewählt

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald nimmt Aktie von CervoMed mit "Overweight" in die Bewertung auf

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

Vielversprechende Studiendaten zu Demenzmittel beflügeln CervoMed-Aktie

CervoMed: Positive Studiendaten für Wirkstoff gegen Lewy-Körper-Demenz

CervoMed’s DLB drug shows promise in phase 2b trial

CervoMed stock soars after promising dementia drug trial results

Neflamapimod reduces key neurodegeneration markers in DLB study

CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates

Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?

Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Beats Revenue Estimates